SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193805-24-000672
Filing Date
2024-05-17
Accepted
2024-05-17 09:03:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da114125002_05172024.htm SC 13D/A 185720
2 PRESS RELEASE, DATED MAY 17, 2024 ex991to13da114125002_051724.pdf SC 13D/A 139819
  Complete submission text file 0001193805-24-000672.txt   380322
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85963 | Film No.: 24957870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12 E. 49TH STREET 40TH FLOOR NEW YORK NY 10017
Business Address 12 E. 49TH STREET 40TH FLOOR NEW YORK NY 10017 2122594370
Whitefort Capital Management, LP (Filed by) CIK: 0001884931 (see all company filings)

IRS No.: 820808818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A